共 76 条
- [1] Kurniasari MD(2021)Forecasting future HIV infection cases: evidence from Indonesia Soc Work Public Health 36 12-25
- [2] Huruta AD(2018)HIV drug resistance in low-income and middle-income countries Lancet HIV 5 e588-e596
- [3] Tsai HT(2021)Avoiding drug resistance in HIV reverse transcriptase Chem Rev 121 3271-3296
- [4] Lee C-W(2019)Review: HIV-1 phylogeny during suppressive antiretroviral therapy Curr Opin HIV AIDS 14 188-193
- [5] Hamers RL(2012)HIV-1 Reverse Transcription Cold Spring Harb Perspect Med 2 a006882-228
- [6] de Wit TFR(2020)HIV-1 transmitted drug resistance surveillance: shifting trends in study design and prevalence estimates J Int AIDS Soc 23 e25611-150
- [7] Holmes CB(2000)The Genetic Basis of HIV-1 Resistance to Reverse Transcriptase and Protease Inhibitors AIDS Rev 2 211-170
- [8] Cilento ME(2019)Long-acting HIV drugs for treatment and prevention Annu Rev Med 70 137-259
- [9] Kirby KA(2013)Systematic review of HIV drug resistance in Southeast Asia AIDS Rev 15 162-560
- [10] Sarafianos SG(2022)PRISMA2020: An R package and Shiny app for producing PRISMA 2020-compliant flow diagrams, with interactivity for optimised digital transparency and Open Synthesis Campbell Syst Rev 18 e1230-166